The binding of 2,3,7,8-tetrachlorodibenzodioxin to plasma lipoproteins may delay toxicity in experimental hyperlipidemia
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 45 (3) , 393-399
- https://doi.org/10.1016/0009-2797(83)90086-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- DIETARY VITAMIN A AND RISK OF CANCER IN THE WESTERN ELECTRIC STUDYThe Lancet, 1981
- Uptake of lipophilic carcinogens by plasma lipoproteins Structure-activity studiesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus.Journal of Clinical Investigation, 1981
- Prolegomena to SevesoArchives of Toxicology, 1980
- Increased total and high density lipoprotein cholesterol with apoprotein changes resembling streptozotocin diabetes in tetrachlorodibenzodioxin (TCDD) treated ratsBiochemical Pharmacology, 1980
- The relationship of serum cholesterol to the incidence of cancer in Evans County, GeorgiaJournal of Chronic Diseases, 1980
- Binding of the chemical carcinogen, p‐dimethylaminoazobenzene, by human plasma low density lipoproteinsFEBS Letters, 1979
- The Origin of AtherosclerosisScientific American, 1977
- The function of sterols in membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1976
- The influence of salts and differences in protein isolation procedure on the binding of quinidine to human serum albuminBiochemical Pharmacology, 1976